Core Laboratories sees Q4 EPS 38c-40c, consensus 41c
Sees Q4 revenue $143M-$145M, consensus $148.84M. Expects activity levels to increase in North America but be offset by continuing weakness in international locations, especially South America and Asia-Pacific regions. Reservoir Description margins are expected to remain at 20% even with anticipated weakness in the international markets while revenues and margins are expected to increase for North American-centric Production Enhancement operations. Expects its revenue growth to ultimately outperform the increase in industry activity rates by 200 to 400 basis points. Core expects to generate incremental operating income margins of approximately 60% early in the activity recovery phase followed by historical incremental operating income margins of approximately 35% to 45% well into the recovery phase.